Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 4
1988 28
1989 68
1990 172
1991 243
1992 295
1993 335
1994 345
1995 310
1996 277
1997 279
1998 280
1999 298
2000 281
2001 297
2002 260
2003 247
2004 244
2005 248
2006 201
2007 210
2008 187
2009 178
2010 162
2011 166
2012 157
2013 111
2014 107
2015 80
2016 70
2017 87
2018 80
2019 89
2020 80
2021 53
2022 53
2023 31
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

6,305 results

Results by year

Filters applied: . Clear all
Page 1
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE. Short NJ, et al. Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2. Lancet. 2018. PMID: 30078459 Free PMC article. Review.
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Larson RA, Mandrekar SJ, Huebner LJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Voso MT, Klisovic RB, Galinsky I, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Gathmann I, Döhner H, Stone RM. Larson RA, et al. Leukemia. 2021 Sep;35(9):2539-2551. doi: 10.1038/s41375-021-01179-4. Epub 2021 Mar 2. Leukemia. 2021. PMID: 33654204 Free PMC article. Clinical Trial.
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Döhner H, Weber D, Krzykalla J, Fiedler W, Wulf G, Salih H, Lübbert M, Kühn MWM, Schroeder T, Salwender H, Götze K, Westermann J, Fransecky L, Mayer K, Hertenstein B, Ringhoffer M, Tischler HJ, Machherndl-Spandl S, Schrade A, Paschka P, Gaidzik VI, Theis F, Thol F, Heuser M, Schlenk RF, Bullinger L, Saadati M, Benner A, Larson R, Stone R, Döhner K, Ganser A. Döhner H, et al. Blood Adv. 2022 Sep 27;6(18):5345-5355. doi: 10.1182/bloodadvances.2022007223. Blood Adv. 2022. PMID: 35486475 Free PMC article. Clinical Trial.
Midostaurin: First Global Approval.
Kim ES. Kim ES. Drugs. 2017 Jul;77(11):1251-1259. doi: 10.1007/s40265-017-0779-0. Drugs. 2017. PMID: 28612232 Review.
Midostaurin approved for FLT3-mutated AML.
Levis M. Levis M. Blood. 2017 Jun 29;129(26):3403-3406. doi: 10.1182/blood-2017-05-782292. Epub 2017 May 25. Blood. 2017. PMID: 28546144 Free article. Review.
KOPI: Kinase inhibitOr Proteome Impact analysis.
Li GX, Zhao T, Wang LC, Choi H, Lim YT, Sobota RM. Li GX, et al. Sci Rep. 2022 Jul 29;12(1):13015. doi: 10.1038/s41598-022-16557-w. Sci Rep. 2022. PMID: 35906361 Free PMC article.
Acute leukemias in 2020: state of the art.
Cerchione C, Martinelli G. Cerchione C, et al. Minerva Med. 2020 Oct;111(5):384-385. doi: 10.23736/S0026-4806.20.07049-4. Epub 2020 Sep 22. Minerva Med. 2020. PMID: 32957743 Free article. No abstract available.
Cell-cycle targeted therapies.
Swanton C. Swanton C. Lancet Oncol. 2004 Jan;5(1):27-36. doi: 10.1016/s1470-2045(03)01321-4. Lancet Oncol. 2004. PMID: 14700606 Review.
Will new agents impact survival in AML?
Rowe JM. Rowe JM. Best Pract Res Clin Haematol. 2019 Dec;32(4):101094. doi: 10.1016/j.beha.2019.101094. Epub 2019 Oct 18. Best Pract Res Clin Haematol. 2019. PMID: 31779986 Review.
6,305 results